» Articles » PMID: 18672088

Histoplasma Capsulatum at the Host-pathogen Interface

Overview
Journal Microbes Infect
Publisher Elsevier
Date 2008 Aug 2
PMID 18672088
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Histoplasma capsulatum is the most common cause of invasive fungal pulmonary disease worldwide. The interaction of H. capsulatum with a host is a complex, dynamic process. Severe disease most commonly occurs in individuals with compromised immunity, and the increasing utilization of immunomodulators in medicine has revealed significant risks for reactivation disease in patients with latent histoplasmosis. Fortunately, there are well developed molecular tools and excellent animal models for studying H. capsulatum virulence and numerous recent advances have been made regarding the pathogenesis of this fungus that will improve our capacity to combat disease.

Citing Articles

Pulmonary Histoplasmosis: A Clinical Update.

Barros N, Wheat J, Hage C J Fungi (Basel). 2023; 9(2).

PMID: 36836350 PMC: 9964986. DOI: 10.3390/jof9020236.


C-type lectin receptor-mediated immune recognition and response of the microbiota in the gut.

Li T, Liu L, Hou Y, Shen S, Wang T Gastroenterol Rep (Oxf). 2019; 7(5):312-321.

PMID: 31687150 PMC: 6821170. DOI: 10.1093/gastro/goz028.


Histoplasma Capsulatum: Mechanisms for Pathogenesis.

Mittal J, Ponce M, Gendlina I, Nosanchuk J Curr Top Microbiol Immunol. 2018; 422:157-191.

PMID: 30043340 PMC: 7212190. DOI: 10.1007/82_2018_114.


Concentration-dependent protein loading of extracellular vesicles released by Histoplasma capsulatum after antibody treatment and its modulatory action upon macrophages.

Baltazar L, Zamith-Miranda D, Burnet M, Choi H, Nimrichter L, Nakayasu E Sci Rep. 2018; 8(1):8065.

PMID: 29795301 PMC: 5966397. DOI: 10.1038/s41598-018-25665-5.


Oropharyngeal histoplasmosis: The diagnosis lies in the biopsy.

Miranda C, Jaker M, Fitzhugh-Kull V, Dever L IDCases. 2017; 11:33-35.

PMID: 29276680 PMC: 5738199. DOI: 10.1016/j.idcr.2017.12.005.


References
1.
Deepe Jr G, Gibbons R . Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis. Infect Immun. 2001; 69(5):3128-34. PMC: 98268. DOI: 10.1128/IAI.69.5.3128-3134.2001. View

2.
Breton G, Adle-Biassette H, Therby A, Ramanoelina J, Choudat L, Bissuel F . Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS. 2005; 20(1):119-21. DOI: 10.1097/01.aids.0000199014.66139.39. View

3.
Zancope-Oliveira R, Reiss E, Lott T, Mayer L, Deepe Jr G . Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun. 1999; 67(4):1947-53. PMC: 96551. DOI: 10.1128/IAI.67.4.1947-1953.1999. View

4.
Deepe Jr G, Gibbons R . Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum. Infect Immun. 2002; 70(7):3759-67. PMC: 128065. DOI: 10.1128/IAI.70.7.3759-3767.2002. View

5.
Long K, Gomez F, Morris R, Newman S . Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J Immunol. 2002; 170(1):487-94. DOI: 10.4049/jimmunol.170.1.487. View